Bosh sahifaOGN • NYSE
add
Organon & Co
9,56 $
Seans yopilganidan keyin:(1,14%)-0,11
9,45 $
Yopilgan:6-iyn, 19:30:14 (GMT-4) · USD · NYSE · Ogohlantirish
Yopilish kursi
9,19 $
Kunlik diapazon
9,28 $ - 9,64 $
Yillik diapazon
8,01 $ - 23,10 $
Bozor kapitalizatsiyasi
2,49 mlrd USD
Oʻrtacha hajm
7,48 mln
Narx/foyda
3,31
Dividend daromadliligi
0,84%
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,51 mlrd | -6,72% |
Joriy xarajat | 516,00 mln | -4,97% |
Sof foyda | 87,00 mln | -56,72% |
Sof foyda marjasi | 5,75 | -53,59% |
Har bir ulushga tushum | 1,02 | -16,39% |
EBITDA | 409,00 mln | -14,61% |
Amaldagi soliq stavkasi | 13,86% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 547,00 mln | -4,87% |
Jami aktivlari | 13,16 mlrd | 10,64% |
Jami passivlari | 12,61 mlrd | 6,51% |
Umumiy kapital | 542,00 mln | — |
Tarqatilgan aksiyalar | 259,96 mln | — |
Narxi/balansdagi bahosi | 4,38 | — |
Aktivlardan daromad | 6,19% | — |
Kapitaldan daromad | 8,55% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 87,00 mln | -56,72% |
Operatsiyalardan naqd pul | 75,00 mln | -1,32% |
Sarmoyadan naqd pul | -172,00 mln | -79,17% |
Moliyadan naqd pul | -75,00 mln | -1,35% |
Naqd pulning sof oʻzgarishi | -128,00 mln | -8,47% |
Boʻsh pul | -73,38 mln | -288,75% |
Haqida
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Tashkil etilgan
1923
Sayt
Xodimlar soni
10 000
